Has Phillip Saccogna, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,658 in general payments to Phillip Saccogna, MD across 164 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Phillip Saccogna, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Phillip Saccogna, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Phillip Saccogna, MD

Otolaryngology · Easley, SCNPI 1154304632

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.7% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Stryker at 43.6% of the total. 2025 is the largest year on record at $1,910, 2.3 times the $842 reported in 2019.

$6,658in general payments, 2019–2025

Across 164 payments — averaging $40.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$3K
Intersect ENT, Inc.$720
Regeneron Healthcare Solutions, Inc.$505
GSK$491
Sanofi$473
Integra Lifesciences Corporation$257
plus $1K from 15 others

What the payments were for

Food & beverage$6,50498%
Education$1542%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	37	$2,905
Intersect ENT, Inc.	10	$720
Regeneron Healthcare Solutions, Inc.	15	$505
GSK	40	$491
Sanofi	23	$473
Integra Lifesciences Corporation	4	$257
AstraZeneca	5	$200
Spirair, Inc.	1	$192
Acclarent, Inc	4	$184
Neurent Medical Limited	2	$151
Optinose US, Inc.	7	$119
3nt Medical	1	$110
Aerin Medical Inc.	3	$69
Merz North America, Inc.	1	$48
Medtronic	2	$48
Alk-abello, Inc	2	$47
Smith+Nephew	2	$38
Amgen	2	$32
Paratek Pharmaceuticals, Inc.	1	$28
Eyevance Pharmaceuticals LLC	1	$21
Omeros Corporation	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XPRESS LOPROFILE$871
ENTELLUS - XPRESS ENT DILATION SYSTEM$667
SeptAlign$383
TURBALIGN$383
PROPEL$377
Acclarent Aera$350
XPRESS ENT DILATION SYSTEM$339
CLARIFIX CRYOTHERAPY DEVICE$303
Inspira Air$211
RELIEVA SPINPLUS NAV$211
TruDi Probe$211
LATERA$174
SHAVER SYSTEM$168
NEUROMARK Device$126
NEUROMARK Radiofrequency Console$126
TEZSPIRE$123
1688$102

How this compares

$6,658 in reported general payments places this provider in the 85th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$479,081

Medicare patients

667

Services billed

5,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	13	$1,370
Ofloxacin	52	$1,065
Ipratropium Bromide	46	$1,001
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	66	$600
Tobramycin-DexamethasoneTobramycin/Dexamethasone	19	$548
Methylprednisolone	86	$401
CefuroximeCefuroxime Axetil	20	$373
Fluticasone Propionate	30	$278
Azithromycin	61	$218
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	30	$205
Cephalexin	19	$186
Prednisone	13	$180
Levothyroxine Sodium	17	$83
Diazepam	57	$55
Gabapentin	33	$22

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Easley

Shaun NguyenCharleston$973K
Rodney SchlosserCharleston$382K
Zachary SolerCharleston$67K
Peter HorwichNorth Charleston$33K
Eugene BrownCharleston$28K
Jason NewmanCharleston$26K
Joshua HornigCharleston$25K
Ashli OrourkeCharleston$21K
Alexandra KejnerCharleston$19K
Evan GraboyesCharleston$18K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →